Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
The RV144 HIV-vaccine trial highlighted the importance of envelope-specific non-neutralizing antibody (nNAb) Fc-mediated functions as immune correlates of reduced risk of infection. Since pre-exposure prophylaxis (PrEP) and HIV-vaccines are being used as a combination prevention strategy in at risk...
Main Authors: | Kimone Leigh Fisher, Jennifer M. Mabuka, Aida Sivro, Sinaye Ngcapu, Jo-Ann Shelley Passmore, Farzana Osman, Bongiwe Ndlovu, Quarraisha Abdool Karim, Salim S. Abdool Karim, Amy W. Chung, Cheryl Baxter, Derseree Archary |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01274/full |
Similar Items
-
Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists.
by: Muki S Shey, et al.
Published: (2016-01-01) -
Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis
by: Cheryl Baxter, et al.
Published: (2019-06-01) -
Higher mucosal antibody concentrations in women with genital tract inflammation
by: Parveen Sobia, et al.
Published: (2021-12-01) -
Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
by: Nomusa M. Zondo, et al.
Published: (2022-09-01) -
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
by: Khanyisile Mngomezulu, et al.
Published: (2021-06-01)